UROSPHERE

L'entreprise UROSPHERE est spécialisée en recherches, études et analyses spécialisées.

Urosphere will present a poster at the EAU congress (from 15 to 19 March 2019). Poster 500:Patard PM et al.,Characterization of bladder organoid cultures.Read more News // News & Events // May 23 2018 DMS : finalisation d'une étude préclinique sur le traitement des dysfonctions érectiles. Voir le communiqué de presseRead more Events // News // News & Events // Oct 31 2017 AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st. Urosphere / Urolead will be represented by Repositive’s CEO Fiona Nielsen at the AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st. Come and meet her at booth 817.Read moreAll news Publications Oncology // Publications // Oct 31 2017 [Poster] Effects of litoxetine on urethral pressure and detrusor overactivity in anesthetized. Effects of litoxetine on urethral pressure and detrusor overactivity in anesthetized female rats. Murielle Méen, Marc Guérard, Stefano Palea, Xavier Gamé, Philippe Lluel 32nd Annual.Read more Publications // Urology // Oct 31 2017 [Poster] Effects of litoxetine on acetic acid-induced detrusor overactivity and striated. Effects of litoxetine on acetic acid-induced detrusor overactivity and striated anal sphincter functions in rabbits: comparison with duloxetine. Fernando Pérez-Martinez, Philippe.Read more Publications // Oct 31 2017 Effect of OBE022, an Oral and Selective Non-Prostanoid PGF2α Receptor Antagonist. Effect of OBE022, an Oral and Selective Non-Prostanoid PGF2α Receptor Antagonist in Combination with Nifedipine for Preterm Labor: A Study on RU486-Induced Pregnant Mice. Oliver Pohl,.